SUMMARY Forty patients with atherosclerotic peripheral vascular disease, as compared to 29 healthy controls, showed a significant increase in platelet number and activity, a neutrophil leucocytosis, and a raised level of several acute-phase reactant proteins (fibrinogen, antithrombin III, factor VIII, and serum globulin). The hyperproteinaemia was associated with increases in plasma-, serum-, and blood-viscosity and is the likely cause of the hyperviscosity of vascular disease.
The term haematological stress syndrome' has been used to describe the non-specific haematological abnormalities that accompany certain acute and chronic disorders. These abnormalities include an increase in platelet number and activity, a leucocytosis, and a raised plasma level of certain proteins that act as acute-phase reactants; the anaemia of chronic disorders may also co-exist. While these changes characteristically accompany inflammatory disorders and malignancy, some of the abnormalities also occur in chronic vascular disease and may contribute to platelet deposition, hyperviscosity, and thrombosis. We in vitro, and a lowered platelet threshold to aggregation with adenosine diphosphate (ADP) ( Table 2 ). There were significant increases in plasma-, serum-, and blood-viscosity (the latter measured at high-, intermediate-, and low-shear rates and adjusted to a standard haematocrit of0-45) (Table 3) , a reduction in fibrinolytic activity (Table 3) , and significant elevations in several acute-phase proteins of a coagulant (fibrinogen, factor VIII, antithrombin III) and non-coagulant (serum globulin) type (Table 4) . Correlations were investigated between viscosity and the larger molecular weight plasma proteins that contribute to it (Table 5) . In vascular disease, globulin correlated more closely than fibrinogen with plasma viscosity. Whole-blood viscosity correlated significantly with plasma and serum viscosity. Fibrinogen, globulin, and serum viscosity all showed Stuart, George, Davies, Aukland, Hurlow a similar level of correlation with whole-blood viscosity.
Discussion
Patients who have recently suffered surgical or accidental trauma, myocardial infarction, or acute infection show a short-term, acute-phase response consisting of increases in platelet number and adhesiveness, plasma-and blood-viscosity, erythrocyte sedimentation rate, and plasma proteins (fibrinogen, factors V and VIII, plasminogen, antithrombin III), together with a temporary lowering of fibrinolytic activity.7-13 It is now realised that these acute changes are part of the stress response to tissue injury and are usually of a non-specific, temporary, and secondary nature.
Although a similar, but longer-term, stress response (the haematological stress syndrome) is known to occur in patients with chronic inflammatory disease and cancer,' it has not been generally appreciated that individual reports of platelet activation,'4-'7 hyperfibrinogenaemia and hyperviscosity,2 18 and reduced fibrinolytic activity '9-2' in patients with atherosclerosis may collectively represent a similar stress response in the steadystate of chronic vascular disease. The patients in the present study showed significant changes, on two occasions, in platelet and neutrophil counts, platelet function and fibrinolysis, and acute-phase reactant proteins; these chronic changes in atherosclerosis comprise many of the abnormalities of the stress response.
It is likely that the hyperviscosity of peripheral vascular disease2 18 22 23 is, in part, a consequence of the chronic hyperfibrinogenaemia, although the correlation between fibrinogen and whole-blood viscosity is stated to be relatively poor, some patients showing hyperviscosity without hyperfibrinogenaemia and vice versa.23 Our patients, however, also showed a significant correlation between wholeblood viscosity and total serum globulin. The raised viscosity of whole-blood, plasma, and serum in these patients is more likely to reflect this increase in level of several large molecular weight blood proteins rather than the hyperfibrinogenaemia alone. long-term studies to establish whether hyperfibrinogenaemia, hyperviscosity, platelet hyperactivity, or reduced fibrinolytic activity is of any aetiological significance in the development of vascular disease rather than a non-specific response to established atherosclerosis. It is also unknown which of these haemostatic abnormalities makes the largest contribution to the thrombotic tendency of atherosclerosis. Since multiple haemostatic abnormalities may co-exist in the severely affected patient, therapy aimed at one of them, for example, platelet hyperactivity, may fail because of the persistence of other abnormalities; this is clearly relevant to current clinical trials of anti-platelet agents in patients with cardiovascular disease.
